This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 1992 May;10(5):679-82.

doi: 10.1200/JCO.1992.10.5.679.

Prognostic factors for breast cancer: have they met their promise?

PMID: 1569440
DOI: 10.1200/JCO.1992.10.5.679

Editorial

Prognostic factors for breast cancer: have they met their promise?

C K Osborne. J Clin Oncol. 1992 May.

. 1992 May;10(5):679-82.

doi: 10.1200/JCO.1992.10.5.679.

Author

PMID: 1569440
DOI: 10.1200/JCO.1992.10.5.679

No abstract available

PubMed Disclaimer

Comment on

Human breast cancer: prognostic significance of the c-erbB-2 oncoprotein compared with epidermal growth factor receptor, DNA ploidy, and conventional pathologic features.
Gasparini G, Gullick WJ, Bevilacqua P, Sainsbury JR, Meli S, Boracchi P, Testolin A, La Malfa G, Pozza F. Gasparini G, et al. J Clin Oncol. 1992 May;10(5):686-95. doi: 10.1200/JCO.1992.10.5.686. J Clin Oncol. 1992. PMID: 1349034
Factors predicting treatment responsiveness and prognosis in node-negative breast cancer. The International (Ludwig) Breast Cancer Study Group.
Neville AM, Bettelheim R, Gelber RD, Säve-Söderbergh J, Davis BW, Reed R, Torhorst J, Golouh R, Peterson HF, Price KN, et al. Neville AM, et al. J Clin Oncol. 1992 May;10(5):696-705. doi: 10.1200/JCO.1992.10.5.696. J Clin Oncol. 1992. PMID: 1569442 Clinical Trial.

Similar articles

Biomarker discordance pre and post neoadjuvant chemotherapy in breast cancer.
Dawood S, Gonzalez-Angulo AM. Dawood S, et al. Cancer Biomark. 2012-2013;12(6):241-50. doi: 10.3233/CBM-130315. Cancer Biomark. 2012. PMID: 23735944 Review.
Patient selection in high-dose chemotherapy trials: relevance in high-risk breast cancer.
García-Carbonero R, Hidalgo M, Paz-Ares L, Calzas J, Gómez H, Guerra JA, Hitt R, Hornedo J, Colomer R, Cortés-Funes H. García-Carbonero R, et al. J Clin Oncol. 1997 Oct;15(10):3178-84. doi: 10.1200/JCO.1997.15.10.3178. J Clin Oncol. 1997. PMID: 9336353
Prognostic Significance of VEGFC and VEGFR1 mRNA Expression According to HER2 Status in Breast Cancer: A Study of Primary Tumors from Patients with High-risk Early Breast Cancer Participating in a Randomized Hellenic Cooperative Oncology Group Trial.
Linardou H, Kalogeras KT, Kronenwett R, Alexopoulou Z, Wirtz RM, Zagouri F, Scopa CD, Gogas H, Petraki K, Christodoulou C, Pavlakis K, Koutras AK, Samantas E, Patsea H, Pectasides D, Bafaloukos D, Fountzilas G. Linardou H, et al. Anticancer Res. 2015 Jul;35(7):4023-36. Anticancer Res. 2015. PMID: 26124351 Clinical Trial.
[Systemic chemotherapy and breast cancer].
Collignon J, Rorive A, Martin M, Andre C, Maweja S, Lifrange E, Coucke P, Jerusalem G. Collignon J, et al. Rev Med Liege. 2011 May-Jun;66(5-6):372-8. Rev Med Liege. 2011. PMID: 21826979 French.
Use of gene-expression profiling to recommend adjuvant chemotherapy for breast cancer.
Henry NL, Hayes DF. Henry NL, et al. Oncology (Williston Park). 2007 Oct;21(11):1301-9; discussion 1311, 1314, 1319. Oncology (Williston Park). 2007. PMID: 18080616 Review.

See all similar articles

Cited by

Do we really need prognostic factors for breast cancer?
Clark GM. Clark GM. Breast Cancer Res Treat. 1994;30(2):117-26. doi: 10.1007/BF00666054. Breast Cancer Res Treat. 1994. PMID: 7949209
New therapeutic possibilities in primary invasive breast cancer.
Cady B, Stone MD, Wayne J. Cady B, et al. Ann Surg. 1993 Sep;218(3):338-47; discussion 347-9. doi: 10.1097/00000658-199309000-00013. Ann Surg. 1993. PMID: 8373276 Free PMC article.
Prospective evaluation of prognostic factors in operable breast cancer.
Hawkins RA, Tesdale AL, Killen ME, Jack WJ, Chetty U, Dixon JM, Hulme MJ, Prescott RJ, McIntyre MA, Miller WR. Hawkins RA, et al. Br J Cancer. 1996 Nov;74(9):1469-78. doi: 10.1038/bjc.1996.567. Br J Cancer. 1996. PMID: 8912547 Free PMC article.
Prediction of outcome of patients with metastatic breast cancer: evaluation with prognostic factors and Nottingham prognostic index.
Liu MT, Huang WT, Wang AY, Huang CC, Huang CY, Chang TH, Pi CP, Yang HH. Liu MT, et al. Support Care Cancer. 2010 Dec;18(12):1553-64. doi: 10.1007/s00520-009-0778-0. Epub 2009 Nov 11. Support Care Cancer. 2010. PMID: 19904562
p-Glycoprotein expression as a predictor of breast cancer recurrence.
Gregorcyk S, Kang Y, Brandt D, Kolm P, Singer G, Perry RR. Gregorcyk S, et al. Ann Surg Oncol. 1996 Jan;3(1):8-14. doi: 10.1007/BF02409045. Ann Surg Oncol. 1996. PMID: 8770296

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal